{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:16:10Z","timestamp":1707524170227},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,7]]},"DOI":"10.7759\/cureus.11958","type":"journal-article","created":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T23:54:51Z","timestamp":1607385291000},"source":"Crossref","is-referenced-by-count":0,"title":["Terbinafine-Induced Hepatitis B Reactivation in a Patient With Chronic Hepatitis B"],"prefix":"10.7759","author":[{"given":"Elona","family":"Shehi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Alemam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikhitha","family":"Mantri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harish","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.10.039","article-title":"American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy","volume":"148","author":"Reddy KR","year":"2015","unstructured":"Reddy KR, Beavers KL, Hammond SP, Lim JK, Falck-Ytter YT, American Gastroenterological Association Institute. American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy. Gastroenterology. 2015, 148:215-219. 10.1053\/j.gastro.2014.10.039","journal-title":"Gastroenterology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.040675","article-title":"Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis","volume":"53","author":"Esteve M","year":"2004","unstructured":"Esteve M, Saro C, Gonzalez-Huix F, Suarez F, Forne M, Viver JM. Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis. Gut. 2004, 53:1363-1365. 10.1136\/gut.2004.040675","journal-title":"Gut"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-148-7-200804010-00008","article-title":"Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy","volume":"148","author":"Loomba R","year":"2008","unstructured":"Loomba R, Rowley A, Wesley R, Hoofnagle JH, Pucino F, Csako G. Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy. Ann Intern Med. 2008, 148:519-528. 10.7326\/0003-4819-148-7-200804010-00008","journal-title":"Ann Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(91)90599-g","article-title":"Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study","volume":"100","author":"Lok AS","year":"1991","unstructured":"Lok AS, Liang RH, Chiu EK, Wong KL, Chan TK, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology. 1991, 100:182-188. 10.1016\/0016-5085(91)90599-g","journal-title":"Gastroenterology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.05.014","article-title":"Transarterial chemo-lipiodolization can reactivate hepatitis B virus replication in patients with hepatocellular carcinoma","volume":"41","author":"Jang JW","year":"2004","unstructured":"Jang JW, Choi JY, Bae SH, et al.. Transarterial chemo-lipiodolization can reactivate hepatitis B virus replication in patients with hepatocellular carcinoma. J Hepatol. 2004, 41:427-435. 10.1016\/j.jhep.2004.05.014","journal-title":"J Hepatol"},{"key":"ref6","article-title":"Outcome after discontinuation of nucleot(s)ide analogues in chronic hepatitis B: relapse rate and associated factors","volume":"28","author":"Kranidioti H","year":"2015","unstructured":"Kranidioti H, Manolakopoulos S, Khakoo SI. Outcome after discontinuation of nucleot(s)ide analogues in chronic hepatitis B: relapse rate and associated factors. Ann Gastroenterol. 2015, 28:173-181.","journal-title":"Ann Gastroenterol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/gut.51.4.597","article-title":"Fatal hepatitis B reactivation following discontinuation of nucleoside analogues for chronic hepatitis B","volume":"51","author":"Lim SG","year":"2002","unstructured":"Lim SG, Wai CT, Rajnakova A, Kajiji T, Guan R. Fatal hepatitis B reactivation following discontinuation of nucleoside analogues for chronic hepatitis B. Gut. 2002, 51:597-599. 10.1136\/gut.51.4.597","journal-title":"Gut"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.03.006","article-title":"Level of hepatitis B virus DNA in inactive carriers with persistently normal levels of alanine aminotransferase","volume":"8","author":"Chu CM","year":"2010","unstructured":"Chu CM, Chen YC, Tai DI, Liaw YF. Level of hepatitis B virus DNA in inactive carriers with persistently normal levels of alanine aminotransferase. Clin Gastroenterol Hepatol. 2010, 8:535-540. 10.1016\/j.cgh.2010.03.006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1H400","article-title":"Terbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infection","volume":"41","author":"Paredes AH","year":"2007","unstructured":"Paredes AH, Lewis JH. Terbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infection. Ann Pharmacother. 2007, 41:880-884. 10.1345\/aph.1H400","journal-title":"Ann Pharmacother"},{"key":"ref10","article-title":"LiverTox: Clinical and Research Information on Drug-Induced Liver Injury","year":"2012","unstructured":"LiverTox. Clinical and Research Information on Drug-Induced Liver Injury. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda; 2012."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-200305000-00008","article-title":"Terbinafine-associated hepatotoxicity","volume":"325","author":"Ajit C","year":"2003","unstructured":"Ajit C, Suvannasankha A, Zaeri N, Munoz SJ. Terbinafine-associated hepatotoxicity. Am J Med Sci. 2003, 325:292-295. 10.1097\/00000441-200305000-00008","journal-title":"Am J Med Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2010.08.010","article-title":"Terbinafine stimulates the pro-inflammatory responses in human monocytic THP-1 cells through an ERK signaling pathway","volume":"87","author":"Mizuno K","year":"2010","unstructured":"Mizuno K, Fukami T, Toyoda Y, Nakajima M, Yokoi T. Terbinafine stimulates the pro-inflammatory responses in human monocytic THP-1 cells through an ERK signaling pathway. Life Sci. 2010, 87:537-544. 10.1016\/j.lfs.2010.08.010","journal-title":"Life Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22945","article-title":"Reactivation of hepatitis B","volume":"49","author":"Hoofnagle JH","year":"2009","unstructured":"Hoofnagle JH. Reactivation of hepatitis B. Hepatology. 2009, 49:156-165. 10.1002\/hep.22945","journal-title":"Hepatology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100998","article-title":"Hepatitis B virus induces a novel inflammation network involving three inflammatory factors, iL-29, iL-8, and cyclooxygenase-2","volume":"187","author":"Yu Y","year":"2011","unstructured":"Yu Y, Gong R, Mu Y, et al.. Hepatitis B virus induces a novel inflammation network involving three inflammatory factors, iL-29, iL-8, and cyclooxygenase-2. J immunol. 2011, 187:4845-4860.  10.4049\/jimmunol.1100998","journal-title":"J immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/42753-terbinafine-induced-hepatitis-b-reactivation-in-a-patient-with-chronic-hepatitis-b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:24:25Z","timestamp":1707506665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/42753-terbinafine-induced-hepatitis-b-reactivation-in-a-patient-with-chronic-hepatitis-b"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,7]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.11958","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,7]]}}}